Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Barings LLC

Barings LLC trimmed its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 28.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,875 shares of the biotechnology company’s stock after selling 1,169 shares during the period. Barings LLC’s holdings in Axon Enterprise were worth $1,709,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Geode Capital Management LLC boosted its position in Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after purchasing an additional 35,320 shares during the period. Westfield Capital Management Co. LP boosted its position in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the period. Champlain Investment Partners LLC boosted its position in Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after purchasing an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after purchasing an additional 9,090 shares during the period. Finally, Groupama Asset Managment purchased a new position in Axon Enterprise in the 3rd quarter valued at about $200,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

AXON opened at $526.40 on Friday. The firm has a market cap of $40.33 billion, a price-to-earnings ratio of 136.02, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The company’s 50-day moving average price is $599.42 and its 200 day moving average price is $529.53. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Wall Street Analyst Weigh In

A number of research firms have weighed in on AXON. TD Cowen began coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target on the stock. in a research report on Thursday, February 20th. Finally, Northland Securities increased their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $587.38.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares in the company, valued at $15,518,239.71. The trade was a 3.96 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,146 shares of company stock worth $3,262,847. 6.10% of the stock is owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.